Literature DB >> 21755434

Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate.

Maher Saleh1, Katerina Nikolitch, Tristan Bourcier, Claude Speeg, David Gaucher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21755434     DOI: 10.1007/s00417-011-1718-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  10 in total

1.  Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery.

Authors:  D F Martin; L A Ficker; H A Aguilar; S K Gardner; L A Wilson; T A Meredith
Journal:  Arch Ophthalmol       Date:  1990-03

Review 2.  Update on the management of primary CNS lymphoma.

Authors:  S Nasir; L M DeAngelis
Journal:  Oncology (Williston Park)       Date:  2000-02       Impact factor: 2.990

3.  Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.

Authors:  N Voorzanger; R Touitou; E Garcia; H J Delecluse; F Rousset; I Joab; M C Favrot; J Y Blay
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

4.  Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.

Authors:  G Velez; P Yuan; C Sung; G Tansey; G F Reed; C C Chan; R B Nussenblatt; M R Robinson
Journal:  Arch Ophthalmol       Date:  2001-10

5.  Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.

Authors:  M D de Smet; V S Vancs; D Kohler; D Solomon; C C Chan
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

Review 6.  Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.

Authors:  Rithwick Rajagopal; J William Harbour
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

7.  High-dose methotrexate for intraocular lymphoma.

Authors:  Tracy T Batchelor; Gina Kolak; Roberto Ciordia; C Stephen Foster; John W Henson
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

8.  IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.

Authors:  Nathalie Cassoux; Alain Giron; Bahram Bodaghi; Thi H C Tran; Sylvie Baudet; Fréderic Davy; Chi C Chan; Phuc Lehoang; Hélène Merle-Béral
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

9.  Intraocular lymphoma. Clinical and histopathologic diagnosis.

Authors:  S M Whitcup; M D de Smet; B I Rubin; A G Palestine; D F Martin; M Burnier; C C Chan; R B Nussenblatt
Journal:  Ophthalmology       Date:  1993-09       Impact factor: 12.079

10.  Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.

Authors:  S Frenkel; K Hendler; T Siegal; E Shalom; J Pe'er
Journal:  Br J Ophthalmol       Date:  2008-03       Impact factor: 4.638

  10 in total
  6 in total

1.  [Primary vitreoretinal lymphoma].

Authors:  D Jaehne; S E Coupland
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

2.  Optical coherence tomography manifestations of primary vitreoretinal lymphoma.

Authors:  Teiko Saito; Nobuyuki Ohguro; Chiharu Iwahashi; Noriyasu Hashida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-01       Impact factor: 3.117

Review 3.  Interleukins and cytokine biomarkers in uveitis.

Authors:  S Balamurugan; Dipankar Das; Murat Hasanreisoglu; Brian C Toy; Mashal Akhter; V K Anuradha; Eliza Anthony; Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

4.  Diagnosing Vitreoretinal Lymphomas-An Analysis of the Sensitivity of Existing Tools.

Authors:  Anahita Sehgal; Jose S Pulido; Arman Mashayekhi; Tatyana Milman; Gabor Gy Deák
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

5.  Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma.

Authors:  Harish Raja; Melissa R Snyder; Patrick B Johnston; Brian P O'Neill; Juline N Caraballo; Joseph G Balsanek; Brian E Peters; Paul A Decker; Jose S Pulido
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

6.  Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies.

Authors:  Benjamin Schrijver; P Martijn Kolijn; Josianne C E M Ten Berge; Nicole M A Nagtzaam; Angelique L C T van Rijswijk; Sigrid M A Swagemakers; Peter J van der Spek; Tom O A R Missotten; Mirjam E J van Velthoven; Joeri de Hoog; P Martin van Hagen; Anton W Langerak; Willem A Dik
Journal:  Acta Ophthalmol       Date:  2021-07-28       Impact factor: 3.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.